Tarsons Products Intrinsic Value
TARSONS • Healthcare
Current Stock Price
₹166.46
Primary Intrinsic Value
₹54.56
Market Cap
₹183.1 Cr
+100.0%
Upside
Median Value
₹332.92
Value Range
₹50 - ₹416
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
TARSONS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹54.56 | ₹43.65 - ₹65.47 | -67.2% | EPS: ₹2.48, Sector P/E: 22x |
| Book Value Method | asset | ₹416.15 | ₹374.53 - ₹457.76 | +150.0% | Book Value/Share: ₹572.73, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹332.92 | ₹299.63 - ₹366.21 | +100.0% | Revenue/Share: ₹392.73, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹332.92 | ₹299.63 - ₹366.21 | +100.0% | EBITDA: ₹132.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹416.15 | ₹332.92 - ₹499.38 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹49.94 | ₹44.95 - ₹54.93 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹49.94 | ₹44.95 - ₹54.93 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹178.77 | ₹160.89 - ₹196.65 | +7.4% | EPS: ₹2.48, BVPS: ₹572.73 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
TARSONS Intrinsic Value Analysis
What is the intrinsic value of TARSONS?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Tarsons Products (TARSONS) is ₹332.92 (median value). With the current market price of ₹166.46, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹49.94 to ₹416.15, indicating ₹49.94 - ₹416.15.
Is TARSONS undervalued or overvalued?
Based on our multi-method analysis, Tarsons Products (TARSONS) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 1.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.40x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Tarsons Products
Additional stock information and data for TARSONS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹114 Cr | ₹42 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹103 Cr | ₹-40 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹84 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹68 Cr | ₹36 Cr | Positive Free Cash Flow | 8/10 |